Parsons Capital Management Inc Relmada Therapeutics, Inc. Call Options Transaction History
Parsons Capital Management Inc
- $1.8 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RLMD
# of Institutions
58Shares Held
9.47MCall Options Held
301KPut Options Held
126K-
Franklin Resources Inc San Mateo, CA1.3MShares$429,7090.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$414,7120.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.23MShares$405,2160.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$189,1930.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$163,3980.04% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $9.44M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...